CovidChloroV1, Main, Exploration, bibRecord, 000B25

The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.

Identifieur interne : 000B25 ( Main/Exploration ); précédent : 000B24; suivant : 000B26

The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.

Auteurs : Amit Malviya [Inde]

Source :

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [ 1878-3511 ] ; 2020.

RBID : pubmed:32738490

Descripteurs français

KwdFr :
- Azithromycine (MeSH), Betacoronavirus (MeSH), Humains (MeSH), Hydroxychloroquine (MeSH), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Pandémies (MeSH), Pneumopathie virale (MeSH).
MESH :
- traitement médicamenteux : Infections à coronavirus.
- épidémiologie : Infections à coronavirus.
- Azithromycine, Betacoronavirus, Humains, Hydroxychloroquine, Pandémies, Pneumopathie virale.

English descriptors

KwdEn :
- Azithromycin (MeSH), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Humans (MeSH), Hydroxychloroquine (MeSH), Pandemics (MeSH), Pneumonia, Viral (MeSH), SARS-CoV-2 (MeSH).
MESH :
- chemical : Azithromycin, Hydroxychloroquine.
- drug therapy : Coronavirus Infections.
- epidemiology : Coronavirus Infections.
- Betacoronavirus, COVID-19, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.

DOI: 10.1016/j.ijid.2020.07.054
PubMed: 32738490
PubMed Central: PMC7388893

Affiliations:

Inde

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001017
to stream Main, to step Curation: 001017

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.</title>
<author><name sortKey="Malviya, Amit" sort="Malviya, Amit" uniqKey="Malviya A" first="Amit" last="Malviya">Amit Malviya</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health And Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India. Electronic address: dramit_malviya@rediffmail.com.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health And Medical Sciences, Mawdiangdiang, Shillong, Meghalaya</wicri:regionArea>
<wicri:noRegion>Meghalaya</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32738490</idno>
<idno type="pmid">32738490</idno>
<idno type="doi">10.1016/j.ijid.2020.07.054</idno>
<idno type="pmc">PMC7388893</idno>
<idno type="wicri:Area/Main/Corpus">001017</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001017</idno>
<idno type="wicri:Area/Main/Curation">001017</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001017</idno>
<idno type="wicri:Area/Main/Exploration">001017</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.</title>
<author><name sortKey="Malviya, Amit" sort="Malviya, Amit" uniqKey="Malviya A" first="Amit" last="Malviya">Amit Malviya</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health And Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India. Electronic address: dramit_malviya@rediffmail.com.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health And Medical Sciences, Mawdiangdiang, Shillong, Meghalaya</wicri:regionArea>
<wicri:noRegion>Meghalaya</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</title>
<idno type="eISSN">1878-3511</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Azithromycine (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Azithromycine</term>
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32738490</PMID>
<DateCompleted><Year>2020</Year>
<Month>10</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>99</Volume>
<PubDate><Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title>
<ISOAbbreviation>Int J Infect Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.</ArticleTitle>
<Pagination><MedlinePgn>310-311</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1201-9712(20)30601-9</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2020.07.054</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malviya</LastName>
<ForeName>Amit</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health And Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India. Electronic address: dramit_malviya@rediffmail.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>Int J Infect Dis</MedlineTA>
<NlmUniqueID>9610933</NlmUniqueID>
<ISSNLinking>1201-9712</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Int J Infect Dis. 2020 Aug;97:396-403</RefSource>
<PMID Version="1">32623082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Int J Infect Dis. 2020 Oct;99:138-139</RefSource>
<PMID Version="1">32745629</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chloroquine</Keyword>
<Keyword MajorTopicYN="Y">Covid 19</Keyword>
<Keyword MajorTopicYN="Y">Evidence</Keyword>
<Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">Prophylaxis</Keyword>
<Keyword MajorTopicYN="Y">Treatment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32738490</ArticleId>
<ArticleId IdType="pii">S1201-9712(20)30601-9</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijid.2020.07.054</ArticleId>
<ArticleId IdType="pmc">PMC7388893</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Ann Intensive Care. 2020 Apr 19;10(1):43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32307609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2461-2462</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379956</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2020 May;20(5):269-270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32273594</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian Heart J. 2020 Mar - Apr;72(2):131-132</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32534688</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 2020 Jul;123:120-126</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32330521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Apr 8;369:m1432</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32269046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14592603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><country name="Inde"><noRegion><name sortKey="Malviya, Amit" sort="Malviya, Amit" uniqKey="Malviya A" first="Amit" last="Malviya">Amit Malviya</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B25 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32738490
   |texte=   The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32738490" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.

The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki